Literature DB >> 21980072

Skp2 is required for incretin hormone-mediated β-cell proliferation.

Shuen-Ing Tschen1, Senta Georgia, Sangeeta Dhawan, Anil Bhushan.   

Abstract

The glucoincretin hormone glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (Ex-4) promote β-cell growth and expansion. Here we report an essential role for Skp2, a substrate recognition component of SCF (Skp, Cullin, F-box) ubiquitin ligase, in promoting glucoincretin-induced β-cell proliferation by regulating the cellular abundance of p27. In vitro, GLP-1 treatment increases Skp2 levels, which accelerates p27 degradation, whereas in vivo, loss of Skp2 prevents glucoincretin-induced β-cell proliferation. Using inhibitors of phosphatidylinositol 3-kinase and Irs2 silencing RNA, we also show that the effects of GLP-1 in facilitating Skp2-dependent p27 degradation are mediated via the Irs2-phosphatidylinositol-3 kinase pathway. Finally, we show that down-regulation of p27 occurs in islets from aged mice and humans, although in these islets, age-dependent accumulation of p16(Ink4a) prevent glucoincretin-induced β-cell proliferation; however, ductal cell proliferation is maintained. Taken together, these data highlight a critical role for Skp2 in glucoincretin-induced β-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21980072      PMCID: PMC3231831          DOI: 10.1210/me.2011-1119

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  33 in total

1.  cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

Authors:  Ulupi S Jhala; Gianluca Canettieri; Robert A Screaton; Rohit N Kulkarni; Stan Krajewski; John Reed; John Walker; Xueying Lin; Morris White; Marc Montminy
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

2.  Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.

Authors:  Yuval Dor; Juliana Brown; Olga I Martinez; Douglas A Melton
Journal:  Nature       Date:  2004-05-06       Impact factor: 49.962

3.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Authors:  A C Carrano; E Eytan; A Hershko; M Pagano
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

4.  Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).

Authors:  Eva Karamitopoulou; Inti Zlobec; Luigi Tornillo; Vincenza Carafa; Thomas Schaffner; Thomas Brunner; Markus Borner; Ioannis Diamantis; Arthur Zimmermann; Luigi Terracciano
Journal:  Pathology       Date:  2010-04       Impact factor: 5.306

5.  Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins.

Authors:  Isabelle Frouin; Alessandra Montecucco; Giuseppe Biamonti; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

6.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Authors:  R L Tuttle; N S Gill; W Pugh; J P Lee; B Koeberlein; E E Furth; K S Polonsky; A Naji; M J Birnbaum
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

7.  beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass.

Authors:  R N Kulkarni; M Holzenberger; D Q Shih; U Ozcan; M Stoffel; M A Magnuson; C R Kahn
Journal:  Nat Genet       Date:  2002-04-01       Impact factor: 38.330

8.  Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass.

Authors:  Senta Georgia; Anil Bhushan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.

Authors:  Hongxiang Hui; Arash Nourparvar; Xiaoning Zhao; Riccardo Perfetti
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

Review 10.  Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.

Authors:  P L Brubaker; D J Drucker
Journal:  Endocrinology       Date:  2004-03-24       Impact factor: 4.736

View more
  18 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

2.  Myc Is Required for Adaptive β-Cell Replication in Young Mice but Is Not Sufficient in One-Year-Old Mice Fed With a High-Fat Diet.

Authors:  Carolina Rosselot; Anil Kumar; Jayalakshmi Lakshmipathi; Pili Zhang; Geming Lu; Liora S Katz; Edward V Prochownik; Andrew F Stewart; Luca Lambertini; Donald K Scott; Adolfo Garcia-Ocaña
Journal:  Diabetes       Date:  2019-07-10       Impact factor: 9.461

3.  Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance.

Authors:  Liansheng Qiu; Jiabao Lv; Yimin Chen; Jiarong Wang; Ruishan Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

4.  Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.

Authors:  Chunhua Dai; Yan Hang; Alena Shostak; Greg Poffenberger; Nathaniel Hart; Nripesh Prasad; Neil Phillips; Shawn E Levy; Dale L Greiner; Leonard D Shultz; Rita Bottino; Seung K Kim; Alvin C Powers
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

5.  Increasing β-cell mass requires additional stimulation for adaptation to secretory demand.

Authors:  Prosenjit Mondal; Woo-Jin Song; Yuanyuan Li; Kil S Yang; Mehboob A Hussain
Journal:  Mol Endocrinol       Date:  2015-01

6.  Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice.

Authors:  Aaron R Cox; Carol J Lam; Matthew M Rankin; Jacqueline S Rios; Julia Chavez; Claire W Bonnyman; Kourtney B King; Roger A Wells; Deepti Anthony; Justin X Tu; Jenny J Kim; Changhong Li; Jake A Kushner
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

Review 7.  How, When, and Where Do Human β-Cells Regenerate?

Authors:  Giorgio Basile; Rohit N Kulkarni; Noel G Morgan
Journal:  Curr Diab Rep       Date:  2019-06-27       Impact factor: 4.810

8.  Repurposing cAMP-modulating medications to promote β-cell replication.

Authors:  Zhenshan Zhao; Yen S Low; Neali A Armstrong; Jennifer Hyoje Ryu; Sara A Sun; Anthony C Arvanites; Jennifer Hollister-Lock; Nigam H Shah; Gordon C Weir; Justin P Annes
Journal:  Mol Endocrinol       Date:  2014-08-01

9.  Nkx6.1 regulates islet β-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors.

Authors:  Jeffery S Tessem; Larry G Moss; Lily C Chao; Michelle Arlotto; Danhong Lu; Mette V Jensen; Samuel B Stephens; Peter Tontonoz; Hans E Hohmeier; Christopher B Newgard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

10.  LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells.

Authors:  Yating Li; Changwen Jing; Xinyi Tang; Yuanyuan Chen; Xiao Han; Yunxia Zhu
Journal:  Endocrine       Date:  2016-04-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.